Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Jon Hyett a Harris Birthright Research Centre for Fetal Medicine,
Department of Obstetrics and Gynaecology, King's College Hospital
Medical School, London SE5 8RX, b Fetal Cardiology Unit, Guy's Hospital,
London SE1 9RT
Correspondence to: Professor Nicolaides
Objectives:
To examine the utility of measuring fetal nuchal translucency thickness in screening for major defects of the
heart and great arteries at 10-14 weeks of gestation.
Design:
Population based cohort study.
Subjects:
29 154 singleton pregnancies with
chromosomally normal fetuses at 10-14 weeks of gestation.
Setting:
Fetal medicine centre in London.
Main outcome measure:
Prevalence of major defects of
the heart and great arteries.
Results:
Of 50 cases with major defects of the
heart and great arteries (prevalence 1.7 per 1000 pregnancies) 28 (56%, 95% confidence interval 42% to 70%) were in the subgroup of
1822 pregnancies with fetal nuchal translucency thicknesses above the 95th centile of the normal range. The positive and negative predictive values for this cut off point of nuchal translucency thickness were
1.5% and 99.9% respectively.
Conclusions:
Measurement of fetal nuchal translucency
thickness
traditionally used to identify fetuses at high risk of
aneuploidy
at 10-14 weeks of gestation can identify a large proportion
of fetuses with major defects of the heart and great arteries.
Key messages
Read all Rapid Responses